SEC Form 4 insider trading filings tracked in real time from EDGAR

Sullivan Christopher Ryan — Chief Financial Officer

Insider trading activity for Sullivan Christopher Ryan sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: Avalo Therapeutics, Inc.
  • Total insider trades: 4
  • Total buy volume: $82K
  • Total sell volume: $179K
  • Last trade: Sep 11, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Sep 10, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 10,185 N/A
Sep 10, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. SELL 10,185 $179K
Sep 10, 2026 Sullivan Christopher Ryan AVTX Avalo Therapeutics, Inc. OTHER 10,185 $82K
Sep 10, 2026 Sullivan Christopher Ryan AAVTX Avalo Therapeutics, Inc. BUY 10,185 $82K

← All executives · Full trades feed